NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Agilon and certain of its officers and/o ...

agilon health, inc. (NYSE:AGL) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Ryan Daniels - William Blair Dean Rosales - Wolfe Research Jailendra Singh - Truist Adam Ron - Bank of America Sean Dodge - RBC Capital Markets Jack Slevin - Jefferies George Hill - Deutsche Bank Sameer Patel - Evercore ISI Operator Hello, everyone, and welcome to the agilon health First Quarter 2024 Earnings Conf ...

For the quarter ended March 2024, Agilon Health (AGL) reported revenue of $1.6 billion, up 41.2% over the same period last year. EPS came in at $0.01, compared to $0.04 in the year-ago quarter.The reported revenue represents a surprise of -0.85% over the Zacks Consensus Estimate of $1.62 billion. With the consensus EPS estimate being -$0.02, the EPS surprise was +150.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0 ...

Exhibit 99.1 agilon health Reports First Quarter 2024 Results Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,000 Continued progress executing performance action plan with focus on driving profitability and enhancing operating efficiency Maintaining full year 2024 guidance for Medical Margin and Adjusted EBITDA AUSTIN, T.X., May 7, 2024 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physici ...

NEW YORK, April 13, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Agilon To ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Agilon Health, Inc. (AGL) is a healthcare services company for seniors. The Zacks Consensus Estimate for its current year earnings has been revised 357.1% downward over the last 60 days.BankFinancial Corporation (BFIN) is a bank holding company for BankFinancial, National Association. The Zacks Consensus Estimate for its current year earnings has been revised 12.6% downward over the last 60 days.Sleep Number Corporation (SNBR) offers ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:agilon health, inc. (AGL) is a senior healthcare provider. The Zacks Consensus Estimate for its current year earnings has been revised 66.7% downward over the last 60 days.Bel Fuse Inc. (BELFB) is a multifaceted technology solutions provider. The Zacks Consensus Estimate for its current year earnings has been revised 20.8% downward over the last 60 days.Driven Brands Holdings Inc. (DRVN) is an automotive service provider. The Zacks Co ...

agilon health, Inc. (NYSE:AGL) Q4 2023 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Matt Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Officer Tim Bensley - Chief Financial Officer Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Ryan Daniels - William Blair Eduardo Ron - Truist Securities Whit Mayo - Leerink Partners Elizabeth Anderson - Evercore ISI Sean Dodge - RBC Capital Markets Stephen Baxter - Wells Fargo George ...

For the quarter ended December 2023, Agilon Health (AGL) reported revenue of $1.06 billion, up 53.1% over the same period last year. EPS came in at -$0.41, compared to -$0.14 in the year-ago quarter.The reported revenue represents a surprise of +0.72% over the Zacks Consensus Estimate of $1.05 billion. With the consensus EPS estimate being -$0.28, the EPS surprise was -46.43%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...